Sudhir Sivakumaran, PhD

Sudhir Sivakumaran, PhD, serves as the Executive Director of the Critical Path for Alzheimer’s Disease (CPAD) consortium at Critical Path Institute (C-Path). Dr. Sivakumaran oversees the overall strategic planning, management and execution of the objectives and goals of the Neuroscience Program and the individual consortia. Dr. Sivakumaran also leads the C-Path Industry Data Sharing Initiative aimed at acquisition and management of CDISC standardized high-relevance clinical trial and observational study datasets in Alzheimer’s disease. Together with the Quantitative Medicine Program, the Data Collaboration Center at C-Path, Dr. Sivakumaran leads our efforts in the generation of novel regulatory-endorsed drug development tools (DDTs) by fostering relationships and engagement with industry, regulatory agencies (FDA, EMA), academia and patient advocacy organizations. The DDTs are intended to accelerate drug development by facilitating effective evaluation of drug efficacy and safety by optimizing novel clinical trial design and advance our understanding of disease progression. Dr. Sivakumaran brings around 20 years of combined academic and industry scientific and management experience with expertise in neurodegeneration and neuropsychiatric disorders such as Epilepsy, Stroke, Alzheimer’s, and Autism. In addition to a bachelor and master’s degree in microbiology obtained from the University of Madras, India, he holds a PhD in Neuroscience from SISSA/ISAS, Trieste, Italy. Dr. Sivakumaran also brings prior experience in computation modeling and analysis from his time at the University of Tokyo in Japan, performing research in systems biology.